SEICAP

Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica (SEICAP), the Spanish Society of Pediatric Allergy, Asthma and Clinical Immunology, is a scientific, non-profit organization, whose aims are to develop and disseminate the knowledge of allergic and immunologic diseases that affect children. Since June 2012 SEICAP has been recognized as a Public Interest Entity.[1] Their field of study includes childhood asthma, rhinitis and conjunctivitis, anaphylaxis, atopic dermatitis, contact dermatitis, urticaria and angioedema, food allergy, drug allergy, allergy to latex, allergy to insect stings, primary immunodeficiency, and other disorders. These conditions are very frequent in children, especially in developed countries,[2][3] and account for a considerable amount of healthcare spending, which has increased especially since the 1990s.[4]

References
  1. "BOE.es - BOE-A-2012-8551 Orden INT/1387/2012, de 31 de mayo, por la que, en ejecución de sentencia se declara de utilidad pública una entidad". www.boe.es.
  2. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733-43.
  3. Patel SP, Järvelin MR, Little MP. Systematic review of worldwide variations of the prevalence of wheezing symptoms in children. Environ Health 2008 Nov 10;7:57. doi: 10.1186/1476-069X-7-57.
  4. Rank MA, Liesinger JT, Ziegenfuss JY, Branda ME, Lim KG, Yawn BP, Li JT, Shah ND. Asthma expenditures in the United States comparing 2004 to 2006 and 1996 to 1998. Am J Manag Care 2012 Sep;18(9):499-504.]


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.